It may be a stroke of good fortune that Optiscan is focusing on the Neurosurgery and Research markets.
The cost benefit equation would be very different. Both looking good I think.
Barrow Neurological Institute, page-5
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $142.0M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 93 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 87339 | 3 |
View Market Depth
| Last trade - 11.06am 18/11/2024 (20 minute delay) ? |
| OIL (ASX) Chart |
Day chart unavailable